How Nutlin-3 disrupts the MDM2-p53 interaction: a theoretical investigation

被引:5
|
作者
Rauf, Shah Md. Abdur [1 ]
Takaba, Hiromitsu [1 ]
Del Carpio, Carlos A. [1 ]
Miyamoto, Akira [1 ,2 ]
机构
[1] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan
[2] Tohoku Univ, NICHe, Aoba Ku, Sendai, Miyagi 9808579, Japan
关键词
MDM2-Nutlin3; interaction; p53; Hydrogen bonds; MIAX; UA-QCMD; MOLECULAR-DYNAMICS SIMULATION; P53; PATHWAY; DEGRADATION; ONCOPROTEIN; ANTAGONISTS; CATALYST; THERAPY; SYSTEM;
D O I
10.1007/s00044-013-0792-0
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The tumor suppressor protein p53 is inhibited while mouse double minute 2 (MDM2) protein binds on its transactivation domain. Overexpression of MDM2 impairs p53 function and are observed in many human tumors. Disruption of MDM2-p53 interaction leads to increased p53 level and restores p53 transcriptional activity. Restoration of p53 activity through inhibiting the interaction between p53 and MDM2 represents a promising approach for cancer therapy. A number of small-molecule p53-MDM2 binding inhibitors have been developed during the past several years. Nutlin-3 has shown a potent and selective small-molecule MDM2 antagonist which has a considerable promise in pre-clinical studies. In this study we investigated theoretically the interaction of Nutlin-3 with MDM2 at atomistic level, and compared to the interaction of p53 with MDM2 to explore the molecular basis of inhibition. In MDM2-p53 model, there are three hydrogen bonding interactions between MDM2 and p53. The lengths of the hydrogen bonds are found to be 2.45, 2.46, and 1.89 whereas interaction energies are -3.82, -3.76, and -5.32 kcal/mol, respectively. The sum of three hydrogen bonding energy is -12.90 kcal/mol. On the other hand, in MDM2-Nutlin-3 model there are four hydrogen bond interactions between MDM2 and Nutlin-3. The bond lengths are found to be 2.29, 1.77, 2.48, and 2.39 whereas interaction energies are -4.21, -6.63, -3.65, and -3.63 kcal/mol, respectively. The sum of three hydrogen bonding energy is -18.12 kcal/mol. From the comparison between two models, it is revealed that MDM2-Nutlin3 model has four hydrogen bonds whereas MDM2-p53 model has three hydrogen bonds. The interaction energy in MDM2-Nutlin-3 is relatively more stable than MDM2-p53 interaction. Due to stronger hydrogen bond interaction with higher interaction energy, Nutlin-3 blocks the p53-binding pocket of MDM2 and thus disrupts the MDM2-p53 interaction and helps to activate p53 pathway of apoptosis.
引用
收藏
页码:1998 / 2006
页数:9
相关论文
共 50 条
  • [41] Signaling to p53: Breaking the MDM2-p53 circuit
    Prives, C
    CELL, 1998, 95 (01) : 5 - 8
  • [42] HIPK2 Regulation by MDM2 Determines Tumor Cell Response to the p53-Reactivating Drugs Nutlin-3 and RITA
    Rinaldo, Cinzia
    Prodosmo, Andrea
    Siepi, Francesca
    Moncada, Alice
    Sacchi, Ada
    Selivanova, Galina
    Soddu, Silvia
    CANCER RESEARCH, 2009, 69 (15) : 6241 - 6248
  • [43] Comparison of the antitumor effects of an MDM2 inhibitor, nutlin-3, in feline lymphoma cell lines with or without p53 mutation
    Mochizuki, Hiroyuki
    Goto-Koshino, Yuko
    Sato, Masahiko
    Fujino, Yasuhito
    Ohno, Koichi
    Tsujimoto, Hajime
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2012, 147 (3-4) : 187 - 194
  • [44] MDM2-p53 Pathway in Hepatocellular Carcinoma
    Meng, Xuan
    Franklin, Derek A.
    Dong, Jiahong
    Zhang, Yanping
    CANCER RESEARCH, 2014, 74 (24) : 7161 - 7167
  • [45] Inhibition of MDM2 by Nutlin-3 Stabilizes p53 and Attenuates Neointimal Hyperplasia via Suppression of Vascular Proliferation and Inflammation
    Hashimoto, Toru
    Ichiki, Toshihiro
    Takeda, Kotaro
    Sunagawa, Kenji
    CIRCULATION, 2009, 120 (18) : S1171 - S1171
  • [46] Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53
    Van Maerken, Tom
    Ferdinande, Liesbeth
    Taildeman, Jasmien
    Lambertz, Irina
    Yigit, Nurten
    Vercruysse, Liesbeth
    Rihani, Ali
    Michaelis, Martin
    Cinatl, Jindrich, Jr.
    Cuvelier, Claude A.
    Marine, Jean-Christophe
    De Paepe, Anne
    Bracke, Marc
    Speleman, Frank
    Vandesompele, Jo
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (22): : 1562 - 1574
  • [47] MDM2 Antagonist Nutlin-3 Stimulates Global DNA Hydroxymethylation by Enhancing p53-TET1 Signaling Axis
    Wu, Danni
    Li, Yao
    Li, Cuiping
    Zhong, Shangwei
    Liu, Baodong
    Hang, Haiying
    Wang, Hailin
    ACS CHEMICAL BIOLOGY, 2023, : 2240 - 2248
  • [48] Isoindolinone based inhibitors of the MDM2-p53 protein-protein interaction
    Kemp, SJ
    Hardcastle, IR
    Ahmed, SU
    Atatreh, NA
    Barrett, P
    Endicott, JA
    Golding, BT
    Griffin, RJ
    Gruber, J
    Hutton, C
    Lunec, J
    Noble, MEM
    Reid, RJ
    Riedinger, C
    Smyth, LA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2735 - U2736
  • [49] Novel inhibitors of the MDM2-p53 interaction featuring carboxylic acid isosteres
    Gonzalez, Ana Z.
    Li, Zhihong
    Beck, Hilary P.
    Canon, Jude
    Chen, Ada
    Chow, David
    Duquette, Jason
    Eksterowicz, John
    Fox, Brian M.
    Fu, Jiasheng
    Huang, Xin
    Houze, Jonathan
    Jin, Lixia
    Li, Yihong
    Ling, Yun
    Lo, Mei-Chu
    Long, Alexander M.
    Mcgee, Lawrence R.
    McIntosh, Joel
    Oliner, Jonathan D.
    Osgood, Tao
    Rew, Yosup
    Saiki, Anne Y.
    Shaffer, Paul
    Wortman, Sarah
    Yakowec, Peter
    Yan, Xuelei
    Ye, Qiuping
    Yu, Dongyin
    Zhao, Xiaoning
    Zhou, Jing
    Olson, Steven H.
    Sun, Daqing
    Medina, Julio C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [50] Structure-Based Design of Novel Inhibitors of the MDM2-p53 Interaction
    Rew, Yosup
    Sun, Daqing
    De Turiso, Felix Gonzalez-Lopez
    Bartberger, Michael D.
    Beck, Hilary P.
    Canon, Jude
    Chen, Ada
    Chow, David
    Deignan, Jeffrey
    Fox, Brian M.
    Gustin, Darin
    Huang, Xin
    Jiang, Min
    Jiao, Xianyun
    Jin, Lixia
    Kayser, Frank
    Kopecky, David J.
    Li, Yihong
    Lo, Mei-Chu
    Long, Alexander M.
    Michelsen, Klaus
    Oliner, Jonathan D.
    Osgood, Tao
    Ragains, Mark
    Saiki, Anne Y.
    Schneider, Steve
    Toteva, Maria
    Yakowec, Peter
    Yan, Xuelei
    Ye, Qiuping
    Yu, Dongyin
    Zhao, Xiaoning
    Zhou, Jing
    Medina, Julio C.
    Olson, Steven H.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) : 4936 - 4954